HP
SYK icon

HealthInvest Partners’s Stryker SYK Stock Holding History

HealthInvest Partners’s Portfolio SYK Stock Details SYK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.53M Buy
30,283
+3,448
+13% +$1.09M 2.57% 15
2026
Q1 		$9.58M Hold
26,835
– – 3.09% 9
2025
Q4 		$9.43M Buy
26,835
+4,066
+18% +$1.48M 3.01% 11
2025
Q3 		$894K Sell
22,769
-4,697
-17% -$1.81M 3.31% 12
2025
Q2 		$10.9M Buy
27,466
+4,468
+19% +$1.67M 4.65% 6
2025
Q1 		$8.56M Sell
22,998
-2,662
-10% -$1.01M 3.78% 10
2024
Q4 		$9.3M Buy
25,660
+2,200
+9% +$815K 4.41% 7
2024
Q3 		$8.48M Buy
23,460
+3,477
+17% +$1.2M 3.98% 8
2024
Q2 		$6.8M Buy
19,983
+4,829
+32% +$1.64M 4.15% 10
2024
Q1 		$5.42M Buy
15,154
+2,352
+18% +$791K 3.3% 7
2023
Q4 		$3.83M Buy
+12,802
New +$3.59M 3% 15
2022
Q4 		$48.4K Buy
+198
New +$44.9K 0.09% 21

Other funds holding SYK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HealthInvest Partners's SYK Position: Q2 2026 in Review

HealthInvest Partners increased its Stryker (SYK) stake by 13% in Q2 2026, buying an estimated $1.09M and bringing the position to 30,283 shares worth $9.53M. The position accounts for 2.57% of the portfolio, ranked #15.

HealthInvest Partners first reported a position in SYK in Q4 2022 and has held it in 12 quarters since. The position peaked at $10.9M in Q2 2025. 2,250 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • HealthInvest Partners held 30,283 shares of Stryker worth $9.53M as of Q2 2026.
  • HealthInvest Partners bought 3,448 Stryker shares in Q2 2026, an estimated $1.09M.
  • Stryker made up 2.57% of HealthInvest Partners's portfolio in Q2 2026, its #15 holding.
  • HealthInvest Partners first reported a position in Stryker in Q4 2022 and has held it in 12 quarters since.
  • HealthInvest Partners's Stryker position peaked at $10.9M in Q2 2025.
  • 2,250 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on HealthInvest Partners's 13F filing for Q2 2026, filed 24 Jul 2026.